# Hernia Repair in Multiply Morbid Patients

> **NCT00930787** · PHASE4 · TERMINATED · sponsor: **LifeCell** · enrollment: 23 (actual)

## Conditions studied

- Ventral Hernia

## Interventions

- **DEVICE:** Strattice Reconstructive Tissue Matrix (Hernia Repair)
- **DEVICE:** Proceed Surgical Mesh (Hernia repair)

## Key facts

- **NCT ID:** NCT00930787
- **Lead sponsor:** LifeCell
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-08
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Stopped early
- **Last updated:** 2013-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00930787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00930787, "Hernia Repair in Multiply Morbid Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00930787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*